Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for LMA Insertion
NCT05298228Unknown
- Sponsor
- Yonsei University
- Start
- Mar 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of remimazolam in orthopedic surgery, sponsored by Yonsei University. Primary endpoints: Median Effective Dose and 95% Effective Dose. Status: unknown.
02
Drugs
remimazolam
03
Conditions
orthopedic surgery
Beyond the preview
Go deeper on NCT05298228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05298228.